NCT00136604 Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m Status COMPLETED Phase PHASE3
NCT00128544 Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE2
NCT00127959 Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection Status COMPLETED Phase PHASE4
NCT00125762 FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy Status COMPLETED Phase NA
NCT00124241 An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE2
NCT00120796 Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) Status TERMINATED Phase PHASE3
NCT00114361 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection Status COMPLETED Phase PHASE3
NCT00107042 Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths Status COMPLETED Phase PHASE2
NCT00106964 Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth Status COMPLETED Phase PHASE4
NCT00100633 Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People Status COMPLETED Phase PHASE1/PHASE2
NCT00096811 Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program Status NO_LONGER_AVAILABLE Phase N/A
NCT00096785 Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection Status COMPLETED Phase PHASE3
NCT00092469 Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00065507 Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation Status COMPLETED Phase PHASE3
NCT00059267 Prevention of Recurrent Hepatitis B After Liver Transplantation Status COMPLETED Phase N/A
NCT00051090 Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV Status WITHDRAWN Phase NA
NCT00051077 Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Status WITHDRAWN Phase PHASE2
NCT00051038 Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients Status COMPLETED Phase PHASE2/PHASE3